Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: Insights from novel microvascular wall models

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 3, 2012, Pages

  Juchem, Gerd ^a   Weiss, Dominik R ^b   Knott, Maria ^a   Senftl, Anton ^a   Förch, Stefan ^a   Fischlein, Theodor ^c   Kreuzer, Eckart ^a   Reichart, Bruno ^a   Laufer, Stefan ^d   Nees, Stephan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Nuremberg Southern Hospital   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Coronary microcirculation; Endothelial cells; Inflammation; Pericytes; Polymorphonuclear leucocytes; Thrombosis

Indexed keywords

6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 1 METHYL 2 QUINOLONE; BAYX 1007; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; PROSTAGLANDIN E2; QUERCETIN DERIVATIVE; QUERCETIN GLUCURONIDE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ARTERIOLE; ARTICLE; BLOOD VESSEL WALL; CELL CULTURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; ENDOTHELIUM CELL; ERYTHROCYTE; HEART MUSCLE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRAULIC CONDUCTIVITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MEDIATOR; MICROCIRCULATION; MICROVASCULARIZATION; NEUTROPHIL; ORGAN DONOR; PERICYTE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; THROMBOCYTE; VEIN THROMBOSIS; VENULE;

ACTINS; ARTERIOLES; BLOOD PLATELETS; BLOOD PROTEINS; CAPILLARIES; CAPILLARY PERMEABILITY; CELLS, CULTURED; CORONARY CIRCULATION; DINOPROSTONE; DRUG SYNERGISM; ENDOTHELIAL CELLS; ERYTHROCYTES; HEMOSTATICS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOTRIENE B4; MYOCARDITIS; PERICYTES; PLATELET ACTIVATING FACTOR; THROMBIN; VENULES;

EID: 84855658680     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00360.2011     Document Type: Article

References (104)

1. Adamson RH, Zeng M, Adamson GN, Lenz JF, Curry FE. PAF-and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. Am J Physiol Heart Circ Physiol 285: H406-H417, 2003.
2. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249, 1996.
3. Andrews RK, Berndt MC. Platelet adhesion: a game of catch and release. J Clin Invest 118: 3009-3011, 2008.
4. Baetscher M, Brune K. An in vitro system for measuring endothelial permeability under hydrostatic pressure. Exp Cell Res 148: 541-547, 1983.
5. Baldwin AL, Thurston G. Mechanics of endothelial cell architecture and vascular permeability. Crit Rev Biomed Eng 29: 247-278, 2001.
6. Balestrieri ML, Castaldo D, Balestrieri C, Quagliuolo L, Giovane A, Servillo L. Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. J Lipid Res 44: 380-387, 2003.
7. Batra S, Rakusan K, Kuo C. Spatial distribution of coronary capillaires: A-V segment staggering. In: Oxygen Transport to Tissue, edited by Rakusan K, Biro GP, Goldstick TK, Turek Z. New York/London: Plenum, 1989, p. 241-247.
8. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 14: 615-631, 1993.
9. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 103: 40-55, 2010.
10. Bennett AS, Luft J, Hampton JC. Morphological classification of vertebrate blood capillaries. Am J Physiol 196: 381-390, 1959.
11. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med 88: 328-333, 1976.
12. Bogatcheva NV, Sergeeva MG, Dudek SM, Verin AD. Arachidonic acid cascade in endothelial pathobiology. Microvasc Res 69: 107-127, 2005.
13. Bogatcheva NV, Verin AD. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76: 202-207, 2008.
14. Bouchard BA, Shatos MA, Tracy PB. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscler Thromb Vasc Biol 17: 1-9, 1997.
15. Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev 64: 328-363, 2010.
16. Casillan AJ, Gonzalez NC, Johnson JS, Steiner DR, Wood JG. Mesenteric microvascular inflammatory responses to systemic hypoxia are mediated by PAF and LTB4. J Appl Physiol 94: 2313-2322, 2003.
17. Curry FE, Zeng M, Adamson RH. Thrombin increases permeability only in venules exposed to inflammatory conditions. Am J Physiol Heart Circ Physiol 285: H2446-H2453, 2003.
18. Dejana E, Corada M, Lampugnani MG. Endothelial cell-to-cell junctions. FASEB J 9: 910-918, 1995.
19. Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res 335: 17-25, 2009.
20. Denis CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol 75: 3-8, 2002.
21. Faioni EM, Mannucci PM. Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis. Leuk Lymphoma 25: 233-245, 1997.
22. Folco G, Murphy RC. Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 58: 375-388, 2006.
23. Fujii E, Irie K, Uchida Y, Ohba K, Muraki T. Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin. Eur J Pharmacol 273: 267-272, 1995.
24. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
25. Ganda S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med 38: 835-842, 2010.
26. Garcia JG. Concepts in microvascular endothelial barrier regulation in health and disease. Microvasc Res 77: 1-3, 2009.
27. Garcia JG, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibri-nolysis 6: 609-626, 1995.
28. Gonzalez-Gallego J, Garcia-Mediavilla MV, Sanchez-Campos S, Tunon MJ. Fruit polyphenols, immunity and inflammation. Br J Nutr 104, Suppl 3: S15-27, 2010.
29. Gordon JL. Endothelium as a modulator of platelet reactivity. Adv Exp Med Biol 192: 419-425, 1985.
30. Greaves MW, Camp RD. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 280: S33-41, 1988.
31. Grega GJ. Contractile elements in endothelial cells as potential targets for drug action. Trends Pharmacol Sci 7: 452-457, 1986.
32. Grega GJ, Adamski SW. The role of venular endothelial cells in the regulation of macromolecular permeability. Microcirc Endothelium Lymphatics 4: 143-167, 1988.
33. He P. Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled? Cardiovasc Res 87: 281-290, 2010.
34. He P, Zhang H, Zhu L, Jiang Y, Zhou X. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. Am J Physiol Heart Circ Physiol 291: H591-H599, 2006.
35. Hubscher SG. Central perivenulitis: a common and potentially important finding in late posttransplant liver biopsies. Liver Transpl 14: 596-600, 2008.
36. Jacobi J, Sela S, Cohen HI, Chezar J, Kristal B. Priming of polymor-phonuclear leukocytes: a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol 290: H2051-H2058, 2006.
37. Johanson CE, Stopa EG, McMillan PN. The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol 686: 101-131, 2011.
38. Juchem G, Weiss DR, Gansera B, Kemkes BM, Mueller-Hoecker J, Nees S. Pericytes in the macrovascular intima: possible physiological and pathogenetic impact. Am J Physiol Heart Circ Physiol 298: H754-H770, 2010.
39. Kim MH, Harris NR, Tarbell JM. Regulation of hydraulic conductivity in response to sustained changes in pressure. Am J Physiol Heart Circ Physiol 289: H2551-H2558, 2005.
40. Kimura M, Dietrich HH, Huxley VH, Reichner DR, Dacey RG. Measurement of hydraulic conductivity in isolated arterioles of rat brain cortex. Am J Physiol Heart Circ Physiol 264: H1788-H1797, 1993.
41. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72: 463-493, 2010.
42. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 14: 44S-54S, 2001.
43. Lai CH, Kuo KH, Leo JM. Critical role of actin in modulating BBB permeability. Brain Res Brain Res Rev 50: 7-13, 2005.
44. Leirisalo-Repo M. The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 75, Suppl 2: 1-3, 1994.
45. Lewandowski M. Zur Lehre von der cerebrospinalflüssigkeit [On the cerebrospinal fluid]. Zentralblatt Klein Forschung 40: 480-494, 1900.
46. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186: 8-18, 2002.
47. Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjem-dahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 20: 2702-2708, 2000.
48. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24: 1015-1022, 2004.
49. Maderna P, Godson C. Lipoxins: resolutionary road. Br J Pharmacol 158: 947-959, 2009.
50. Magrone T, Jirillo E. Polyphenols from red wine are potent modulators of innate and adaptive immune responsiveness. Proc Nutr Soc 69: 279-285, 2010.
51. McDonald DM. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol Lung Cell Mol Physiol 266: L61-L83, 1994.
52. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6: 7-22, 1999.
53. McGee JE, Fitzpatrick FA. Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci USA 83: 1349-1353, 1986.
54. Mehta RS. Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors). Expert Rev Hematol 3: 227-241, 2010.
55. Mehta RS. Novel oral anticoagulants. Part II: direct thrombin inhibitors. Expert Rev Hematol 3: 351-361, 2010.
56. Michaux G, Cutler DF. How to roll an endothelial cigar: the biogenesis of Weibel-Palade bodies. Traffic 5: 69-78, 2004.
57. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflügers Arch 459: 807-816, 2010.
58. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751, 2000.
59. Minami T, Sugiyama A, Wu SQ, Abid R, Kodama T, Aird WC. Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol 24: 41-53, 2004.
60. Nakagawa S, Deli MA, Nakao S, Honda M, Hayashi K, Nakaoke R, Kataoka Y, Niwa M. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell Mol Neurobiol 27: 687-694, 2007.
61. Nees S, Gerlach E, Des Rosiers C, Bock M, Becker BF, Herzog V. Recent knowledge about the metabolic regulation of coronary circulation, with a contribution on adenine nucleotide metabolism of coronary endothelial cells. Z Kardiol 74, Suppl 7: 87-91, 1985.
62. Nees S, Herzog V, Becker BF, Bock M, Des Rosiers C, Gerlach E. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 80: 515-529, 1985.
63. Nees S, Juchem G, Eberhorn N, Thallmair M, Förch S, Knott M, Senftl A, Fischlein T, Reichart B, Weiss DR. Wall structures of myocardial precapillary arterioles and postcapillary venules reexamined and reconstructed in vitro for studies on barrier functions. Am J Physiol Heart Circ Physiol 302: H51-H68, 2012.
64. Nees S, Weiss DR, Senftl A, Knott M, Förch S, Schnurr M, Weyrich P, Juchem G. Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: the second most frequent myocardial cell type in vitro. Am J Physiol Heart Circ Physiol 302: H69-H84, 2012.
65. Pearson JD, Gordon JL. Nucleotide metabolism by endothelium. Annu Rev Physiol 47: 617-627, 1985.
66. Powell T, Twist VW. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 72: 327-333, 1976.
67. Qiao RL, Sadurski R, Bhattacharya J. Hydraulic conductivity of ischemic pulmonary venules. Am J Physiol Lung Cell Mol Physiol 264: L382-L386, 1993.
68. Rao LV, Pendurthi UR. Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis. Mol Cell Biochem 253: 131-140, 2003.
69. Raschke P, Becker BF, Leipert B, Schwartz LM, Zahler S, Gerlach E. Postischemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid. Basic Res Cardiol 88: 321-339, 1993.
70. Remick DG. Interleukin-8. Crit Care Med 33: S466-467, 2005.
71. Rodrigues SF, Granger DN. Role of blood cells in ischaemia-reperfu-sion induced endothelial barrier failure. Cardiovasc Res 87: 291-299, 2010.
72. Rose AG, Cooper DK. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplanta-tion 7: 31-41, 2000.
73. Rumbaut RE, Wang J, Huxley VH. Differential effects of l-NAME on rat venular hydraulic conductivity. Am J Physiol Heart Circ Physiol 279: H2017-H2023, 2000.
74. Runkle EA, Antonetti DA. The blood-retinal barrier: structure and functional significance. Methods Mol Biol 686: 133-148, 2011.
75. Rybina IV, Liu H, Gor Y, Feinmark SJ. Regulation of leukotriene A4 hydrolase activity in endothelial cells by phosphorylation. J Biol Chem 272: 31865-31871, 1997.
76. Sala A, Bolla M, Zarini S, Muller-Peddinghaus R, Folco G. Release of leukotriene A4 versus leukotriene B4 from human polymorphonuclear leukocytes. J Biol Chem 271: 17944-17948, 1996.
77. Samuelsson B. Arachidonic acid metabolism: role in inflammation. Z Rheumatol 50 Suppl 1: 3-6, 1991.
78. Serafini M, Peluso I, Raguzzini A. Flavonoids as anti-inflammatory agents. Proc Nutr Soc 69: 273-278, 2010.
79. Serban DN, Nilius B, Vanhoutte PM. The endothelial saga: the past, the present, the future. Pflügers Arch 459: 787-792, 2010.
80. Serhan CN, Levy B. Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem Immunol Allergy 83: 115-145, 2003.
81. Shapiro H, Lev S, Cohen J, Singer P. Polyphenols in the prevention and treatment of sepsis syndromes: rationale and pre-clinical evidence. Nutrition 25: 981-997, 2009.
82. Shen Q, Rigor RR, Pivetti CD, Wu MH, Yuan SY. Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 87: 272-280, 2010.
83. Sies H, Schewe T, Heiss C, Kelm M. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 81: 304S-312S, 2005.
84. Simionescu M, Simionescu N. Ultrastructure of the microvascular wall: functional correlations. In: Handbook of Physiology. The Cardiovascular System. Microcirculation, edited by Renkin E, Michel C. Bethesda, MD: Am. Physiol. Soc., sect 2, vol 4, 1984, p. 41-101.
85. Simionescu M, Simionescu N, Palade GE. Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol 67: 863-885, 1975.
86. Song M, Kellum JA. Interleukin-6. Crit Care Med 33: S463-S465, 2005.
87. Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circ Res 107: 1170-1184, 2010.
88. Strange C, Gottehrer A, Birmingham K, Heffner JE. Platelets attenuate oxidant-induced permeability in endothelial monolayers: glutathio-ne-dependent mechanisms. J Appl Physiol 81: 1701-1706, 1996.
89. Tabuchi A, Kuebler WM. Endothelium-platelet interactions in inflammatory lung disease. Vascul Pharmacol 49: 141-150, 2008.
90. Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol 30: 2357-2361, 2010.
91. Valeski JE, Baldwin AL. Role of the actin cytoskeleton in regulating endothelial permeability in venules. Microcirculation 10: 411-420, 2003.
92. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 39: 257-272, 2002.
93. Vanderhoek JY. Role of the 15-lipoxygenase in the immune system. Ann NY Acad Sci 524: 240-251, 1988.
94. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412, 2008.
95. Victorino GP, Newton CR, Curran B. Modulation of microvascular hydraulic permeability by platelet-activating factor. J Trauma 56: 379-384, 2004.
96. Voisin MB, Probstl D, Nourshargh S. Venular basement membranes ubiquitously express matrix protein low-expression regions: characterization in multiple tissues and remodeling during inflammation. Am J Pathol 176: 482-495, 2010.
97. Weiss DR, Juchem G, Kemkes BM, Gansera B, Nees S. Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med 2: 95-113, 2009.
98. Wittig J, Herderich M, Graefe EU, Veit M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatog-raphy-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 753: 237-243, 2001.
99. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, Gibbins JM. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related fla-vonoids. Br J Pharmacol 159: 1312-1325, 2010.
100. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci USA 76: 4498-4502, 1979.
101. Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol 172: 1-7, 2008.
102. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116: 3211-3219, 2006.
103. Zhu L, He P. fMLP-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol 290: H365-H372, 2006.
104. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301, 2002.